SPOTLIGHT -
A Call for Your Reflections on 9/11
Professionally and personally, how have you reacted to and recovered from the tragic events on 9/11?
8:46 Shock and Reflections
Two traumatic events... the same timing.
Posttraumatic Growth: Reflections on 9/11
It's been 20 years since the 9/11 attacks. What have we learned?
Clinically Based Policy Decisions: In-Person Requirements for Telehealth Create Unnecessary Barriers
Medicare's in-person requirement threatens access to quality care.
To Treat or Not to Treat? The Conundrum of Likeability
Treating patients who may be perceived as “unlikeable” can be difficult.
Psychiatric Evaluation of the Peripartum Patient
How can you be better prepared to interview and care for peripartum patients? This CME shows you how.
Stopping Our Intergenerational Transmission of War Humiliation
Hubris, humiliation, and revenge: the downfall of societies.
The State of America’s Mental Health Requires Putting Ourselves First
A new report paints a dismal picture of mental health in America, especially for clinicians.
Phone Numbers to Know for National Suicide Prevention Month
These phone numbers could save a life...
Reflecting on Trauma
The long trail of posttraumatic pain and suffering leaves behind too many people whose lives will never be the same...
Contagious Philosophy and Perspectives
Taking a page from African philosophy that emphasizes the importance of humanity into the psychiatric realm.
Psychiatry Comic: Gene Editor
This rejection was DNA-deep...
The Anniversary Effect of 9/11
What can be done to help patients turn painful memories into opportunities for posttraumatic growth?
FDA Workshop Plans to Discuss Potential Mandatory Opioid Prescriber Education
The FDA is holding a workshop to discuss mandatory opioid prescriber education through the Opioid Analgesic Risk Evaluation and Mitigation Strategy.
Turning Over a New Leaf
As the seasons change and new possibilities open up, we also pause to remember the victims of September 11 and the ongoing opioid crisis.
Why I Wrote a Clinical Memoir
A psychiatrist’s memoir dispels common misconceptions about the profession and offers lessons from decades of practice.
An Integrative Paradigm for Mental Health Care: Ideas and Methods Shaping the Future
This book is a rich roadmap on how to bring discipline and direction to integrative medicine.
From Languishing to Flourishing: The Impact of the COVID-19 Pandemic
What can be done to mitigate stress and reduce burnout?
In Memoriam: The Meaning of Age 75 in the Lives of Psychiatrists
Is life past age 75 worth living?
9/11 20th Anniversary: COVID-19 Endgame
How has human behavior been affected by the tragedy of 9/11 and the recent trauma of the COVID-19 pandemic?
Nasal Spray for Treatment of Migraine Approved by FDA
The first and only treatment to use proprietary precision olfactory delivery technology to deliver DHE to the upper nasal cavity just received FDA approval.
An Overlooked Strategy for Antidepressant Augmentation?
A hypnotic might be a good option for augmenting depression treatment, but which hypnotic has the best evidence for efficacy?
When We’re Flooded With News
In this new series, you will find reflections on psychiatry and society as seen in—and inspired by—current events.
The Case for Caution When Prescribing Benzodiazepines
Are benzodiazepine prescriptions contributing to the opioid overdose epidemic?
APA and Other Leading Physician Groups Oppose Texas Legislation That Interferes With Patient Reproductive Care
6 frontline physician groups expressed their concern about the Texas state law that bans abortions after 6 weeks of pregnancy.
Elegy for a Wounded Summer
The summer began with such promise. Where did it go? And what hope can we see in the future?
When to Use Mirtazapine Augmentation
After a string of disappointing results, mirtazapine gets another look in a recent study.
Psychiatry Comic: The Best Alternative Medicine
Moms do it best.
Reflections on Women’s Health
The newest law in Texas dictating women's health brings with it many issues for consideration.
First and Only Twice-Yearly Treatment for Schizophrenia Receives FDA Approval
The one-of-its-kind 6-month paliperidone palmitate treatment for schizophrenia has received FDA approval.
